Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Repurposing old drugs to fight multidrug resistant cancers
Jelena Dinić, Thomas Efferth, Alfonso T. García‐Sosa, et al.
Drug Resistance Updates (2020) Vol. 52, pp. 100713-100713
Open Access | Times Cited: 80

Showing 51-75 of 80 citing articles:

Protein Expression Profiling and Virtual Drug Screening as an Approach for Individualized Therapy of Small Cell Vaginal Carcinoma
Mohamed E.M. Saeed, Hassan E. Khalid, SAILESH K. THAKUR, et al.
Cancer Genomics & Proteomics (2022) Vol. 19, Iss. 4, pp. 512-525
Open Access | Times Cited: 7
CRISPR-dCas9-Based Artificial Transcription Factors to Improve Efficacy of Cancer Treatment With Drug Repurposing: Proposal for Future Research
Alejandro Martinez‐Escobar, Benjamín Luna-Callejas, Eva Ramón‐Gallegos
Frontiers in Oncology (2021) Vol. 10
Open Access | Times Cited: 9
In Vivo Antitumoral Effects of Linseed Oil and Its Combination With Doxorubicin
О. И. Шадыро, Anna Sosnovskaya, Irina Edimecheva, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 6
Protein-Ligand Docking Simulations with AutoDock4 Focused on the Main Protease of SARS-CoV-2
Walter Filgueira de Azevedo, Gabriela Bitencourt‐Ferreira, Joana Retzke Godoy, et al.
Current Medicinal Chemistry (2021) Vol. 28, Iss. 37, pp. 7614-7633
Closed Access | Times Cited: 8
Towards an Integral Therapeutic Protocol for Breast Cancer Based upon the New H+-Centered Anticancer Paradigm of the Late Post-Warburg Era
Salvador Harguindey, Khalid O. Alfarouk, Julián Polo Orozco, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 20, pp. 7475-7475
Open Access | Times Cited: 6
Downregulation of BUBR1 regulates the proliferation and cell cycle of breast cancer cells and increases the sensitivity of cells to cisplatin
Yiran Lu, Ruiqing Wang, Song He, et al.
In Vitro Cellular & Developmental Biology - Animal (2023) Vol. 59, Iss. 10, pp. 778-789
Closed Access | Times Cited: 2
Anticancer activities, structure–activity relationship, and mechanism of action of 12‐, 14‐, and 16‐membered macrolactones
Ruo Wang
Archiv der Pharmazie (2021) Vol. 354, Iss. 9
Closed Access | Times Cited: 5
Towards An Integral Therapeutic Protocol for Breast Cancer based upon the New H+-Centered Anticancer Paradigm of the Late Post-Warburg Era
Salvador Harguindey, Khalid O. Alfarouk, Julián Polo Orozco, et al.
(2020)
Open Access | Times Cited: 4
Repurposing Drugs for Overcoming Therapy Resistance in Colon Cancer – A Review
Mahdi Darvishi, Amir Chekeni, Mohammad Fazelhosseini, et al.
Journal of Angiotherapy (2024) Vol. 8, Iss. 2
Open Access
Proteasome and PARP1 dual-target inhibitor for multiple myeloma: Fluzoparib
Kai Deng, Qiongqiong Li, Lina Lu, et al.
Biochemistry and Biophysics Reports (2024) Vol. 39, pp. 101781-101781
Open Access
Pharmacophore Modelling and Virtual Screening
Manos C. Vlasiou
BENTHAM SCIENCE PUBLISHERS eBooks (2024), pp. 48-62
Closed Access
Assessment of the Anticancer Effects of Simvastatin on Human Osteosarcoma and Colorectal Cancer Cell Lines
Sarah Mazin Naeem, Ayad Ali Hussein
Kufa Medical journal (2024) Vol. 20, Iss. 2, pp. 161-170
Open Access
Migrastatic Therapy as a Potential Game-Changer in Adaptive Cancer Treatment
Katharina Schneider, Louise Spekking, Sepinoud Azimi, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Identification and characterization of deschloro-chlorothricin obtained from a large natural product library targeting aurora A kinase in multiple myeloma
Nadire Özenver, Sara Abdelfatah, Anette Klinger, et al.
Investigational New Drugs (2020) Vol. 39, Iss. 2, pp. 348-361
Open Access | Times Cited: 3
Lokal anesteziklerden levobupivakain ve ropivakain kolon kanseri tedavisinde kullanılabilir mi?
Nazmiye Bıtgen, Gözde Özge Önder, Özlem Öz Gergı̇n, et al.
Çukurova medical journal (Online)/Çukurova medical journal (2023) Vol. 48, Iss. 1, pp. 161-167
Open Access | Times Cited: 1
Analysis of Gene Expression Networks in Primary Central Nervous System Tumors for Drug Repurposing Prospects
B. Villanueva, Po‐Wei Tsai, Lemmuel L. Tayo
(2023)
Open Access | Times Cited: 1
ANALYTICAL UV SPECTROSCOPY METHOD DEVELOPMENT AND VALIDATION STUDIES FOR SIMULTANEOUS ESTIMATION OF METFORMIN HCL AND QUERCETIN
Rushikesh Mali, Tabassum Khan
INDIAN DRUGS (2023) Vol. 60, Iss. 11, pp. 82-87
Closed Access | Times Cited: 1
Novel hybrid virtual screening protocol based on pharmacophore and molecular docking for discovery of GSK‐3β inhibitors
Xiaochang Liu, Jiaxue Yu, Yong-Yan Luo, et al.
Chemical Biology & Drug Design (2022) Vol. 101, Iss. 2, pp. 326-339
Closed Access | Times Cited: 2
Repurposing of Immunomodulators for the Treatment of Cancer with QSAR Approaches
Rajiv Kumar Tonk, Vivek Yadav, Ramesh K. Goyal
(2023), pp. 283-297
Closed Access
Repurposing Drugs: A New Paradigm and Hopes for Life-threatening Diseases
Ruchi Chawla, Varsha Rani, Krishan Kumar, et al.
BENTHAM SCIENCE PUBLISHERS eBooks (2023), pp. 1-24
Closed Access
Discovery of anticancer therapeutics: Computational chemistry and Artificial Intelligence-assisted approach
Subrata Das, Anupam Das Talukdar, Deepa Nath, et al.
Elsevier eBooks (2023), pp. 19-41
Closed Access
In Vitro and In Silico Analysis of the Anti-cancer Effects of Eurycomanone and Eurycomalactone from <em>Eurycoma longifolia.</em>
N. M. Yunos, Habibah A. Wahab, Mohammad G. Al‐Thiabat, et al.
(2023)
Open Access
A Systematic Review of Literatures: To Identify Non-Cancer Drugs Repurposed for Lung Cancer
Saikat Samadder
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Scientific output on coronavirus and WHO’s Solidarity Project: a science-based choice?
Andréia Cristina Galina, Deise Schröder Sarzi, Larissa Campos de Medeiros, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access
Editorial on the Special Issue: “Multidrug Combinations”
Nuno Vale
Biomolecules (2022) Vol. 12, Iss. 6, pp. 812-812
Open Access

Scroll to top